ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Lung Cancer

Breast Cancer trials near Paris, Île-de-France, FRA:

Evaluation of Mobiderm Intimate Bra in the Management of Breast Edema Related to Breast Cancer Treatment (MOBIBRA)

The aim of this exploratory study is to assess the performance and tolerability of the MOBIDERM Intimate Bra in the management of breast ede ...

Not yet enrolling
Breast Cancer Surgery
Device: Mobiderm Intimate Bra group
THUASNE

Paris, Paris 14, France

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

Active, not recruiting
Breast Cancer Stage II
Breast Cancer Stage III
Drug: doxorubicin/cyclophosphamide
Drug: Docetaxel / cyclophosphamide

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Saint-Cloud, France and 72 other locations

non-metastatic early-stage triple-negative (TNBC) or HER2+ breast cancer. TNBC cohort is composed of 4 open-label, randomized arms,...

Enrolling
Breast Cancer
Drug: Pertuzumab
Drug: Ipatasertib

Phase 2

Gustave Roussy

Villejuif, France

Govitecan (SG) in locally advanced or metastatic triple-negative breast cancer where the disease has progressed despite chemotherap...

Enrolling
Metastatic Breast Cancer
Triple Negative Breast Cancer
Drug: Sacituzumab govitecan

Phase 3

Unicancer
Unicancer

Villejuif, France

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Tucatinib

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Villejuif Cedex, France and 71 other locations

-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this study, anti-h...

Enrolling
Breast Cancer Recurrent
Drug: Standard endocrine therapy
Drug: Palbociclib 125mg

Phase 3

ETOP IBCSG Partners Foundation

Villejuif, France and 52 other locations

This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...

Active, not recruiting
Metastatic Breast Cancer
FGFR 1 High Amplification
Drug: Futibatinib
Drug: Futibatinib plus Fulvestrant

Phase 2

Taiho Pharma
Taiho Pharma

Villejuif, Cedex, France and 36 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo

Paris Cedex 05, Paris, France and 226 other locations

dose of MEN1611 to be used in combination with Trastuzumab with/without Fulvestrant for the treatment of advanced or metastatic HER2-positive breast...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Fulvestrant
Drug: MEN1611

Phase 1

Menarini
Menarini

Villejuif cedex, France and 26 other locations

This study aims to evaluate the efficacy and safety of U3-1402 in participants with advanced breast cancer (ABC). Participants have...

Enrolling
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

Gustave Roussy

Villejuif, France

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems